At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our
Drive and implement the GPS system and processes strategy within allocated area of responsibility, Reporting, Process or Systems. Accountable for the performance and accuracy of systems in close collaboration with operational and Tech counterparts. Represent GPS
Global Competitive Intelligence Director m/f/d YOUR TASKS AND RESPONSIBILITIES The Competitive Intelligence Director is a key member of the cross functional GSI (Global Strategic Insights) team directly supporting Product Teams in developing and executing the global commercialization and
Company Description At Intuitive, we are united behind our mission: we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints. As a
The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development
The Process Development Lead is a key leadership role within Technical Operations, responsible for leading global process development teams and driving the development, optimization, and implementation of robust and scalable manufacturing processes for plasma-derived biotherapeutics. This role
Background The position is located within the Group on Earth Observations (GEO) Secretariat. The Director will lead, facilitate and support activities of the Group on Earth Observations (GEO), based on the direction and supervision provided by the
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Job Scope: What is this job’s focus? The Associate Director, EU CTR Strategy & Operations Excellence supports the Head of EU CTR in providing leadership and strategic oversight for the implementation, optimization, and continuous improvement of all EU
About This Role The Senior Medical Director, Global Medical Affairs, Nephrology will be a strategic partner providing expert medical leadership to guide medical strategy development, launch planning, and support for our Glomerular Nephritis programs, including IgAN and
Job Description Are You Ready to Make It Happen at Mondelēz International? Join our Mission to Lead the Future of Snacking. Make It Uniquely Yours. We are seeking a highly motivated and experienced Senior Director, Global Internal
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement.read on In 2015, we pioneered a “moneyball for biotech”
Deadline for Applications July 7, 2026 Hardship Level H (no hardship) Family Type Family Residential location (if applicable) Grade DI2 Staff Member / Affiliate Type Professional ReasonRegular Regular Assignment Target Start Date 2026-08-01 Standard Job Description
Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department.
BandLevel 5 Job Description SummaryAs Associate Director, Biomedical Research (BR) Data & Digital Software & Workflows AI Engineering Manager, you will lead a team of internal and external AI engineers to deliver initiative aligned production grade AI
Salary Range:CHF142,100.00 - CHF263,900.00 Job Description SummaryLI#- Hybrid Location: Basel, Switzerland As a Therapeutic Area Biomarker Lead (TABL) in the Biomarker Development (BMD) group, you are accountable for defining and delivering biomarker strategies for the Immunology
Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)